Building natural products
Natural products are molecules produced by living organisms and include some of our most powerful drugs. Emerging discoveries in this field have allowed scientists to deepen our understanding of how natural products are assembled and how they can be harnessed for widespread applications.
Submit an abstract
Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30.
This program at Discover BMB 2024 is focused on recent advances in natural product biochemistry and biotechnology. The first session focuses on the emerging area of natural products from higher eukaryotes and animals; the second session focuses on natural products from microbiomes and symbionts; and the final session focuses on the biochemistry and biotechnology of natural product genome mining.
We’ll hear about the amazing discoveries in this field, some of which were powered by major technological advances. We’ll also hear how discoveries in natural products biochemistry are now in turn powering new applications in biotechnology related to biocatalysis, agriculture and sustainable chemical production.
Keywords: Natural products, biocatalysis, microbiome.
Who should attend: Anyone interested in natural products, biocatalysis, the microbiome or the future of biotechnology.
Theme song: by Jefferson Airplane
This session is powered by alkaloids.
Advances in natural products biochemistry and technology
Natural products from higher eukaryotes and animals
Chair: Yi Tang
Bradley Moore, University of California, San Diego
Rebecca Butcher, University of Florida
Emily Derbyshire, Duke University
Jing-Ke Weng, Whitehead Institute for Biomedical Research
Natural products from microbiomes and symbionts
Chair: Katherine Ryan
Jason Crawford, Yale University
Nancy Keller, University of Wisconsin—Madison
Alessandra Eustaquio, University of Illinois Chicago
Mohammad Seyedsayamdost, Princeton University
Biochemistry and biotechnology of natural product genome mining
Chair: Alessandra Eustaquiol
Jamie Link, Princeton University
Katherine Ryan, University of British Columbia
Gerald Wright, McMaster University
Yi Tang, University of California, Los Angeles
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
How scientists identified a new neuromuscular disease
NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.
Unraveling cancer’s spaghetti proteins
MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.
How HCMV hijacks host cells — and beyond
Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.
Understanding the lipid link to gene expression in the nucleus
Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.
Receptor antagonist reduces age-related bone loss in mice
Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.
Engineered fusion protein targets kiwifruit pathogen
Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.